Mirae Asset Global ETFs Holdings
UTHR icon

Mirae Asset Global ETFs Holdings’s United Therapeutics UTHR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
4,920
-368
-7% -$207K ﹤0.01% 1111
2026
Q1 		$3.13M Sell
5,288
-541
-9% -$269K ﹤0.01% 992
2025
Q4 		$2.85M Sell
5,829
-730
-11% -$340K ﹤0.01% 1003
2025
Q3 		$2.75M Buy
6,559
+78
+1% +$26.2K ﹤0.01% 1003
2025
Q2 		$1.86M Buy
6,481
+165
+3% +$49.3K ﹤0.01% 1133
2025
Q1 		$1.94M Sell
6,316
-130
-2% -$44.6K ﹤0.01% 1155
2024
Q4 		$2.28M Buy
6,446
+1,342
+26% +$493K ﹤0.01% 1064
2024
Q3 		$1.83M Sell
5,104
-2,876
-36% -$972K ﹤0.01% 1185
2024
Q2 		$2.54M Buy
+7,980
New +$2.11M 0.01% 973

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Mirae Asset Global ETFs Holdings's UTHR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its United Therapeutics (UTHR) stake by 7% in Q2 2026, selling an estimated $207K and leaving 4,920 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Mirae Asset Global ETFs Holdings first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.13M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 4,920 shares of United Therapeutics worth $2.67M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 368 United Therapeutics shares in Q2 2026, an estimated $207K.
  • United Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1111 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's United Therapeutics position peaked at $3.13M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.